Skip to main content
INBIOGEN CO.,Ltd logo

INBIOGEN CO.,Ltd — Investor Relations & Filings

Ticker · 101140 ISIN · KR7101140002 KO Professional, scientific and technical activities
Open in API
Filings indexed 342 across all filing types
Latest filing 2023-03-16 AGM Information
Country KR South Korea
Listing KO 101140

About INBIOGEN CO.,Ltd

https://www.inbiogen.com/

INBIOGEN is a life sciences company that provides Virtual Biotech Assistance to international biotechnology companies, pharmaceutical firms, and research organizations. The company specializes in harnessing data mining to deliver a range of services, including bioinformatics, custom data curation, database development, and the creation of operational platforms. Core bioinformatics offerings encompass data analysis, protein modeling, homology searches, phylogeny, and immunogenicity analysis. Additionally, INBIOGEN provides virtual research, marketing assistance, and web development services. The company focuses on creating customized, value-added solutions through a team of experienced scientists and bioinformatics professionals to help clients address challenges and utilize online resources effectively.

Recent filings

Filing Released Lang Actions
주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) for the company Inbiogen. It outlines the date, location, and specific agenda items (such as financial statement approval, director appointments, and business purpose changes). This type of document is a standard proxy solicitation material used to inform shareholders of an upcoming meeting and request their participation/votes, which falls under the Proxy Solicitation & Information Statement category.
2023-03-16 Korean
주주총회집중일개최사유신고
AGM Information Classification · 95% confidence The document is a formal regulatory filing submitted to the KRX (Korea Exchange) regarding the 'Reason for holding a General Meeting of Shareholders on a concentrated date'. It explains why the company scheduled its AGM on a date that conflicts with other companies' meetings. Since this is a regulatory disclosure regarding meeting logistics rather than the meeting materials themselves (AGM-R) or a proxy statement (PSI), it falls under the general regulatory filing category.
2023-03-16 Korean
[기재정정]주요사항보고서(전환사채권발행결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) from a South Korean company, Inbiogen, specifically detailing an amendment (정정신고) to a previously filed convertible bond issuance. It outlines changes to the maturity date, conversion terms, and call/put option details. In the context of Korean regulatory filings (DART system), this is a standard disclosure regarding capital structure changes and financing, which falls under the 'Capital/Financing Update' category.
2023-03-16 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a 'Notice of General Meeting of Shareholders' (주주총회소집공고) for Inbiogen. It contains the agenda for the upcoming annual general meeting, including items such as the approval of financial statements, election of directors, and remuneration limits. It also includes detailed management information, such as board activity reports and financial statements (balance sheet and income statement) for the fiscal year. This type of document is a standard proxy statement/information circular provided to shareholders to solicit votes and inform them of meeting details, which falls under the 'Proxy Solicitation & Information Statement' category.
2023-03-16 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Major Shareholding Notification Classification · 100% confidence The document is a Korean regulatory filing titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). This is a standard disclosure form required by the Financial Supervisory Service (FSS) in South Korea when a major shareholder or executive changes their stake in a company. This falls under the category of Major Shareholding Notification (MRQ) as it details the change in share ownership percentage and specific holdings of a major shareholder (Bucket Studio) in the issuing company (Inbiogen).
2023-01-06 Korean
기타경영사항(자율공시)
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing from the Korea Exchange (KRX) system regarding the conversion of convertible preferred shares into common shares. This involves a change in the company's capital structure and share count. According to the filing definitions, 'Share Issue/Capital Change' (SHA) is the appropriate category for announcements regarding new share issues or capital changes resulting from conversions.
2022-12-30 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.